These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 8823321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R, Holford T, Farber LR, Prosnitz LR, Cooper DL.
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL, Tucker MA, Hoppe RT.
    J Natl Cancer Inst; 1993 Jan 06; 85(1):25-31. PubMed ID: 8416252
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 06; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 10. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
    Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD.
    Int J Radiat Oncol Biol Phys; 2003 Jan 01; 55(1):36-43. PubMed ID: 12504034
    [Abstract] [Full Text] [Related]

  • 11. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
    van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.
    J Natl Cancer Inst; 2003 Jul 02; 95(13):971-80. PubMed ID: 12837833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT, Ha CS, Hagemeister FB, Fuller LM, Rodriguez MA, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):609-16. PubMed ID: 9336140
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M.
    Clin Cancer Res; 2006 Nov 01; 12(21):6487-93. PubMed ID: 17085663
    [Abstract] [Full Text] [Related]

  • 16. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT.
    N Engl J Med; 1996 Mar 21; 334(12):745-51. PubMed ID: 8592547
    [Abstract] [Full Text] [Related]

  • 17. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
    Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC.
    J Clin Oncol; 2000 Feb 21; 18(3):498-509. PubMed ID: 10653865
    [Abstract] [Full Text] [Related]

  • 18. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C, Veraguth A, Lütolf UM.
    Strahlenther Onkol; 1994 Mar 21; 170(3):140-6. PubMed ID: 8160093
    [Abstract] [Full Text] [Related]

  • 19. Second cancers following pediatric Hodgkin's disease.
    Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS.
    J Clin Oncol; 1998 Feb 21; 16(2):536-44. PubMed ID: 9469338
    [Abstract] [Full Text] [Related]

  • 20. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
    Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF, Boice JD, Gilbert E.
    J Natl Cancer Inst; 2002 Feb 06; 94(3):182-92. PubMed ID: 11830608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.